VIR

Vir Biotechnology, Inc.

11.53 USD
0.00 (0.00%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Vir Biotechnology, Inc. stock is up 20.73% since 30 days ago. The next earnings date is May 2, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 40% of the previous 4 February’s closed higher than January. In the last 3 Unusual Options Trades, there were 1 PUT, 2 CALLs. 50% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
25 Jan 15:06 19 Jul, 2024 12.50 PUT 100 4
25 Jan 19:11 19 Apr, 2024 12.50 CALL 749 974
29 Jan 19:31 19 Jul, 2024 10.00 CALL 450 43

About Vir Biotechnology, Inc.

Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs, for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus. The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health.

  • HC Wainwright & Co.
    Wed Feb 14, 06:39
    buy
    confirm
  • JP Morgan
    Mon Jan 29, 06:04
    hold
    downgrade